Neo Ivy Capital Management - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2022$22,000
+144.4%
4,078
+537.2%
0.02%
+53.8%
Q4 2021$9,000
-62.5%
640
-37.1%
0.01%
-53.6%
Q3 2021$24,000
-69.6%
1,017
-78.1%
0.03%
-68.2%
Q4 2020$79,000
+229.2%
4,639
+356.1%
0.09%
+877.8%
Q2 2020$24,000
-42.9%
1,017
-56.9%
0.01%
-86.8%
Q1 2020$42,000
-93.3%
2,357
-87.7%
0.07%
-86.2%
Q4 2018$628,00019,1130.49%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
Virtus ETF Advisers LLC 72,018$230,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders